Compound ID | 563
Class: Fluoroquinolone
Spectrum of activity: | Gram-negative |
Details of activity: | Activity against MRSA and CAP |
Institute where first reported: | Daiichi Pharmaceutical; Pfizer |
Year first mentioned: | 2001 |
Highest developmental phase: | Phase 1 |
Development status: | Inactive |
Reason Dropped: | Pfizer and Daiichi announced discontinuation of this antibiotic in 2004 after analysis of Phase I trial data |
Chemical structure(s): | |
Canonical SMILES: | COC1=C(C(=CC2=C1N(C=C(C2=O)C(=O)O)[C@@H]3C[C@@H]3F)F)N4C[C@H](C5(CC5)C4)N |
Isomeric SMILES: | COC1=C2C(=CC(=C1N3C[C@H](C4(C3)CC4)N)F)C(=O)C(=CN2[C@@H]5C[C@@H]5F)C(=O)O |
InChI: | InChI=1S/C20H21F2N3O4/c1-29-18-15-9(17(26)10(19(27)28)6-25(15)13-5-11(13)21)4-12(22)16(18)24-7-14(23)20(8-24)2-3-20/h4,6,11,13-14H,2-3,5,7-8,23H2,1H3,(H,27,28)/t11-,13+,14+/m0/s1 |
InChI Key: | JYRHGXXQSIPDDP-IACUBPJLSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/5271826 |
External links: | |
Guide to Pharmacology: | DK-507k |
Main Source: | https://journals.asm.org/doi/10.1128/aac.47.12.3750-3759.2003 |